Analysis of Therapeutic Options for Noise-Induced... (2024 study) Skip to main content
Study Noise Health 2024

Analysis of Therapeutic Options for Noise-Induced Hearing Loss: Retroauricular Injection of Methylprednisolone Sodium Succinate Combined with Hyperbaric Oxygenation

Yao Y, Li L, Noise Health, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers compared two treatments for noise-induced hearing loss: steroid injection alone versus steroid injection combined with hyperbaric oxygen therapy.

What They Found

This retrospective study reviewed records of 220 patients with noise-induced hearing loss, with 158 receiving retroaural methylprednisolone injection combined with hyperbaric oxygen and 62 receiving the injection alone. Among patients with low-frequency, high-frequency, or flat descending type hearing loss, and among patients whose treatment began within 7 days of onset, the combined-treatment group had a significantly higher clinical effective rate than the injection-only group (p less than 0.05). Adverse reaction rates were 8.23% in the combined-treatment group and 9.68% in the injection-only group, a difference the study reports as not statistically significant (p greater than 0.05).

Canadian Relevance

No direct Canadian connection identified. The study was conducted at Zhongda Hospital, Southeast University, China.

Study Limitations

This was a retrospective, non-randomized comparison at a single hospital, with patients assigned by treatment plan rather than random allocation, which limits how confidently the results can be attributed to the hyperbaric oxygen component alone.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 39345079
Year Published 2024
Journal Noise Health
MeSH Terms Humans; Hyperbaric Oxygenation; Methylprednisolone Hemisuccinate; Male; Female; Middle Aged; Hearing Loss, Noise-Induced; Adult; Combined Modality Therapy; Injections; Treatment Outcome; Glucocorticoids; Retrospective Studies; Aged

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology